1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Predictive Biosciences

Anonymous Board for Predictive Biosciences

Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    8
    Views:
    6,181
  2. Anonymous
    Replies:
    6
    Views:
    3,429
  3. Anonymous
    Replies:
    6
    Views:
    6,163
  4. Anonymous
    Replies:
    0
    Views:
    5,415
  5. Anonymous
    Replies:
    12
    Views:
    5,006
  6. Anonymous
    Replies:
    0
    Views:
    3,997
  7. Anonymous
    Replies:
    5
    Views:
    3,193
  8. Anonymous
    Replies:
    9
    Views:
    4,587
  9. Anonymous
    Replies:
    3
    Views:
    4,469
  10. Anonymous
    Replies:
    1
    Views:
    3,815
  11. Anonymous
    Replies:
    31
    Views:
    10,563
  12. Anonymous
    Replies:
    8
    Views:
    4,259
  13. Anonymous
    Replies:
    2
    Views:
    3,629
  14. Anonymous
    Replies:
    25
    Views:
    7,581
  15. Anonymous
    Replies:
    3
    Views:
    3,059
  16. Anonymous
    Replies:
    6
    Views:
    3,841
  17. Anonymous
    Replies:
    3
    Views:
    2,737
  18. Anonymous
    Replies:
    1
    Views:
    2,610
  19. Anonymous
    Replies:
    6
    Views:
    2,821
  20. Anonymous
    Replies:
    10
    Views:
    3,481

Thread Display Options

Loading...